Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul Medipol University Hospital
About this trial
The investigators aimed to compare the home-based Pulmonary Rehabilitation with the hospital-based pulmonary rehabilitation in terms of pulmonary rehabilitation efficiency in patient with bronchiectasis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between the ages of 18-70
Patients signing informed consent form
Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT).
Disqualifiers
Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure> 200, Diastolic Blood Pressure> 110),
Additional diseases that may prevent exercise,
To be regularly exercising regularly
Trial design
Design model
Parallel
Treatments tested in this trial
Hospital-based pulmonary rehabilitation
Other interventionThe patients who undergo two days pulmonary rehabilitation under supervision in our clinic and three days a week at home during two months will taken as hospital group. The exercises include breathing exercises, treadmill (15sc), cycle training (15sc), arm ergometer training (15sc), peripheral muscle training and stretching exercises with free weights.
Home-based pulmonary rehabilitation
Other interventionThe patients who follow a home-based pulmonary rehabilitation program for two months comprising breathing exercises, training in chest hygiene techniques, peripheral muscle strengthening training and self-walking for 5 days in a week for two months. An exercise follow-up form will give to the patients to record their daily exercises. A similar form will fill by physiotherapist once a week during phone call.
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: Hospital-based groupExperimental treatment 1 intervention
Group B: Home-based groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Changes from baseline the 6-minute walking distance at two months.
Time frame
Two months2
Changes from baseline the modified Medical Research Council (mMRC) scale at two months.
Dyspnea perceptions during daily life activities will assess according to the modified Medical Research Council (mMRC) scale. The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. "0" means no dyspnea perception, "4" means severe dyspnea perception.
Time frame
Two monthsSecondary outcomes
1
Changes from baseline the forced expiratory volume in one second at two months.
The Pulmonary Function Test conducted using a Sensor Medics model 2400 device (Yorba Linda, CA, USA), in line with American Thoracic Society (ATS) guidelines.
Time frame
Two months2
Changes from baseline the peripheral muscle strength at two months.
Peripheral Muscle Strength will measure using a digital dynamometer(J-Tech Commander muscle testing device), with three measurements make in total of the quadriceps femoris, tibialis anterior and iliopsoas muscles.
Time frame
Two months3
Changes from baseline the Quality of Life at two months.
St. George Respiratory Questionnaire
Time frame
Two monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov